Milton J. Wallace, Director at Catalyst Pharmaceutical Partners, Inc. (CPRX), bought 100 shares at $2.06 ($206) on 2009-05-22, disclosed to the SEC on 2009-05-27.
Open-market purchase of $206 CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CPRX | BUY | 2012-05-29 | $100K | — | Filing → |
| IPII | BUY | 2011-08-18 | $1K | — | Filing → |
| IPII | BUY | 2011-06-02 | $340 | — | Filing → |